FTC outlines antitrust case against Edwards’ $945M JenaValve acquisition
The Federal Trade Commission (FTC) has begun outlining its case against Edwards Lifesciences’ proposed purchase of heart implant developer JenaValve after the antitrust agency announced it would move to block…